Arunee Thitithanyanont

3.5k total citations · 1 hit paper
99 papers, 2.1k citations indexed

About

Arunee Thitithanyanont is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Arunee Thitithanyanont has authored 99 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Infectious Diseases, 33 papers in Epidemiology and 23 papers in Immunology. Recurrent topics in Arunee Thitithanyanont's work include SARS-CoV-2 and COVID-19 Research (29 papers), Influenza Virus Research Studies (25 papers) and Viral gastroenteritis research and epidemiology (16 papers). Arunee Thitithanyanont is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (29 papers), Influenza Virus Research Studies (25 papers) and Viral gastroenteritis research and epidemiology (16 papers). Arunee Thitithanyanont collaborates with scholars based in Thailand, Taiwan and United States. Arunee Thitithanyanont's co-authors include Suwimon Manopwisedjaroen, Suradej Hongeng, Chak Sangma, Prasert Auewarakul, Waranyoo Phoolcharoen, Balamurugan Shanmugaraj, Pilaipan Puthavathana, Kaewta Rattanapisit, Sheng‐Fan Wang and Peter A. Lieberzeit and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Arunee Thitithanyanont

98 papers receiving 2.1k citations

Hit Papers

Anti-SARS-CoV-2 Activity of Andrographis paniculata Extra... 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arunee Thitithanyanont Thailand 25 830 671 630 497 290 99 2.1k
Barbara S. Schnierle Germany 30 819 1.0× 792 1.2× 470 0.7× 542 1.1× 110 0.4× 84 2.5k
Andrew J. Thompson United States 28 364 0.4× 1.0k 1.5× 800 1.3× 300 0.6× 146 0.5× 51 2.1k
Ze Chen China 30 722 0.9× 603 0.9× 1.5k 2.4× 896 1.8× 172 0.6× 108 2.5k
Qinxue Hu China 34 1.3k 1.5× 984 1.5× 764 1.2× 1.0k 2.1× 82 0.3× 101 3.5k
Andreas Grassauer Austria 20 280 0.3× 514 0.8× 453 0.7× 405 0.8× 70 0.2× 28 1.8k
Yoshikazu Honda‐Okubo Australia 20 524 0.6× 354 0.5× 576 0.9× 423 0.9× 77 0.3× 67 1.5k
Valeria Cagno Switzerland 25 524 0.6× 545 0.8× 489 0.8× 296 0.6× 126 0.4× 58 1.8k
Xiangguo Qiu Canada 35 2.8k 3.3× 804 1.2× 1.1k 1.7× 220 0.4× 345 1.2× 109 3.8k
Ka‐Cheung Luk United States 18 1.4k 1.7× 575 0.9× 713 1.1× 623 1.3× 45 0.2× 40 3.1k
Anke Huckriede Netherlands 37 822 1.0× 1.3k 2.0× 1.6k 2.6× 1.6k 3.3× 81 0.3× 117 4.0k

Countries citing papers authored by Arunee Thitithanyanont

Since Specialization
Citations

This map shows the geographic impact of Arunee Thitithanyanont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arunee Thitithanyanont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arunee Thitithanyanont more than expected).

Fields of papers citing papers by Arunee Thitithanyanont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arunee Thitithanyanont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arunee Thitithanyanont. The network helps show where Arunee Thitithanyanont may publish in the future.

Co-authorship network of co-authors of Arunee Thitithanyanont

This figure shows the co-authorship network connecting the top 25 collaborators of Arunee Thitithanyanont. A scholar is included among the top collaborators of Arunee Thitithanyanont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arunee Thitithanyanont. Arunee Thitithanyanont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manopwisedjaroen, Suwimon, Ekawat Pasomsub, Aalok Basu, et al.. (2025). Evidence of Mpox clade IIb infection in primary human alveolar epithelium. Emerging Microbes & Infections. 14(1). 2477845–2477845. 1 indexed citations
2.
Manopwisedjaroen, Suwimon, et al.. (2024). Unveiling the Antiviral Properties of Panduratin A through SARS-CoV-2 Infection Modeling in Cardiomyocytes. International Journal of Molecular Sciences. 25(3). 1427–1427. 1 indexed citations
3.
Rattanapisit, Kaewta, et al.. (2024). Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamiana. Human Vaccines & Immunotherapeutics. 20(1). 4 indexed citations
4.
Muangnoicharoen, Sant, Saranath Lawpoolsri, Sira Nanthapisal, et al.. (2024). Heterologous Ad26.COV2.S booster after primary BBIBP-CorV vaccination against SARS-CoV-2 infection: 1-year follow-up of a phase 1/2 open-label trial. Vaccine. 42(19). 3999–4010. 2 indexed citations
5.
Phoolcharoen, Waranyoo, Balamurugan Shanmugaraj, Narach Khorattanakulchai, et al.. (2023). Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant. Vaccine. 41(17). 2781–2792. 12 indexed citations
6.
Wiriyarat, Witthawat, Nithi Asavapanumas, Phongthon Kanjanasirirat, et al.. (2023). Pharmacological Activities of Fingerroot Extract and Its Phytoconstituents Against SARS-CoV-2 Infection in Golden Syrian Hamsters. Journal of Experimental Pharmacology. Volume 15. 13–26. 10 indexed citations
7.
Aiewsakun, Pakorn, et al.. (2023). Systematic Exploration of SARS-CoV-2 Adaptation to Vero E6, Vero E6/TMPRSS2, and Calu-3 Cells. Genome Biology and Evolution. 15(4). 11 indexed citations
8.
Muangnoicharoen, Sant, Sira Nanthapisal, Anan Jongkaewwattana, et al.. (2023). Single Ad26.COV2.S Booster Dose Following Two Doses of BBIBP-CorV Vaccine Against SARS-CoV-2 Infection in Adults: Day 28 Results of a Phase 1/2 Open-Label Trial. SSRN Electronic Journal. 1 indexed citations
9.
Jongkaewwattana, Anan, Nawamin Pinpathomrat, Sira Nanthapisal, et al.. (2023). Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants. International Journal of Infectious Diseases. 129. 19–31. 6 indexed citations
10.
Srichatrapimuk, Sirawat, Thanat Chookajorn, Theerarat Kochakarn, et al.. (2022). SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period. Travel Medicine and Infectious Disease. 46. 102271–102271. 3 indexed citations
11.
Apiwattanakul, Nopporn, Suwimon Manopwisedjaroen, Samart Pakakasama, et al.. (2022). Target Enrichment Metagenomics Reveals Human Pegivirus-1 in Pediatric Hematopoietic Stem Cell Transplantation Recipients. Viruses. 14(4). 796–796. 2 indexed citations
12.
Manopwisedjaroen, Suwimon, Chompunuch Boonarkart, Pawinee Kupatawintu, et al.. (2022). Dynamics of Neutralizing Antibodies and Binding Antibodies to Domains of SARS-CoV-2 Spike Protein in COVID-19 Survivors. Viral Immunology. 35(8). 545–552. 2 indexed citations
13.
Suksatu, Ampa, Phongthon Kanjanasirirat, Suwimon Manopwisedjaroen, et al.. (2021). Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir. Biomedicines. 9(9). 1230–1230. 14 indexed citations
14.
Sa‐ngiamsuntorn, Khanit, Ampa Suksatu, Yongyut Pewkliang, et al.. (2021). Anti-SARS-CoV-2 Activity of Andrographis paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives. Journal of Natural Products. 84(4). 1261–1270. 136 indexed citations breakdown →
15.
Phoolcharoen, Waranyoo, et al.. (2021). Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay. Scientific Reports. 11(1). 20383–20383. 26 indexed citations
16.
Anurathapan, Usanarat, Nopporn Apiwattanakul, Samart Pakakasama, et al.. (2020). Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling. Bone Marrow Transplantation. 55(12). 2359–2360. 18 indexed citations
17.
Barbazan, Philippe, et al.. (2008). Detection of H5N1 Avian Influenza Virus from Mosquitoes Collected in an Infected Poultry Farm in Thailand. Vector-Borne and Zoonotic Diseases. 8(1). 105–110. 33 indexed citations
18.
Thitithanyanont, Arunee, Anneke Engering, Peeraya Ekchariyawat, et al.. (2007). High Susceptibility of Human Dendritic Cells to Avian Influenza H5N1 Virus Infection and Protection by IFN-α and TLR Ligands. The Journal of Immunology. 179(8). 5220–5227. 89 indexed citations
19.
Damgaard, Christian Kroun, Prasert Auewarakul, Arunee Thitithanyanont, et al.. (2006). The Effect of a Single Nucleotide Substitution in the Splicing Silencer in the tat/rev Intron on HIV Type 1 Envelope Expression. AIDS Research and Human Retroviruses. 22(1). 76–82. 4 indexed citations
20.
Thitithanyanont, Arunee, Luis Mendoza, Ampaiwan Chuansumrit, et al.. (1998). Use of an Immunotherapeutic Vaccine to Treat a Life-Threatening Human Arteritic Infection Caused by Pythium insidiosum. Clinical Infectious Diseases. 27(6). 1394–1400. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026